This is a firm fixed price contract for characterizing azithromycin efficacy against carbapenem-resistant gram-negative bacteria in bicarbonate containing culture media.
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40123C00128
- Awardee
-
University Of Southern California UEI G88KLJR3KYT5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $249,478
Award facts
- Contract value 100% obligated
- $249,478.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Two Step
- Pricing
- Firm Fixed Price
- Place of performance
- Los Angeles, CA 90089, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $249,478 |
About this award
This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the University of Southern California (USC) for $249,478.00 to characterize the efficacy of azithromycin against carbapenem-resistant gram-negative bacteria in bicarbonate-containing culture media. The contract does not have a set-aside designation and has a completion date of December 31, 2024.
USC is a well-established private research university that regularly performs work for the federal government through contract and grant awards. USC has a history of providing services to agencies such as the FBI, DHS, and Department of the Navy in areas like aviation safety training and certification, as well as data analysis, software development, and technical services in domains like cybersecurity, AI, and quantum computing for the DoD, NSF, and DOE. USC also has substantial experience conducting research across various fields, including environmental health, biomedical sciences, and space exploration, through prime and sub-recipient grants from agencies like NIH and NASA.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Beckman Research Institute Of The City Of Hope | $15,571 |
Quick answers
Who was awarded contract 75F40123C00128?
75F40123C00128 was awarded to University Of Southern California by Food and Drug Administration (Department of Health and Human Services) on September 18, 2023.
How much is contract 75F40123C00128 worth?
The government has obligated $249,478 on 75F40123C00128.
Was contract 75F40123C00128 competed?
The extent of competition for 75F40123C00128 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award